Literature DB >> 16520449

Development of pediatric comorbidity prediction model.

Derek Tai1, Paul Dick, Teresa To, James G Wright.   

Abstract

OBJECTIVE: To develop a comorbidity model for children that can be used with hospital discharge administrative databases.
DESIGN: Retrospective study using administrative data obtained from the Canadian Institute for Health Information Discharge Abstract Database and the Deaths File to develop a logistic regression model. Hosmer-Lemeshow chi2 test was used to examine model fit. The C statistic was used to assess model discrimination. Bootstrapping was used to determine the stability of regression coefficients.
SETTING: We used linked administrative databases to compile 339,077 hospital discharge abstracts from April 1, 1991, through March 31, 2002. PARTICIPANTS: Children between ages 1 and 14 years in Ontario, Canada. MAIN OUTCOME MEASURE: Death within 1 year of hospital discharge.
RESULTS: The 27-variable pediatric comorbidity model predicted 1-year mortality with a C statistic of 0.83 in the Ontario data set from which it was derived. The presence of brain cancer (odds ratio, 76.38 [95% confidence interval, 53.40-109.27]) at hospital admission was the strongest predictor, followed by diabetes insipidus (odds ratio, 39.23 [95% confidence interval, 20.75-74.17]).
CONCLUSION: Using clinical judgment and empirical modeling strategies, we were able to identify 27 diagnoses highly predictive of death for children between 1 and 14 years of age within 1 year of hospital discharge.

Entities:  

Mesh:

Year:  2006        PMID: 16520449     DOI: 10.1001/archpedi.160.3.293

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  8 in total

1.  Impact of the AYA HOPE Comorbidity Index on Assessing Health Care Service Needs and Health Status among Adolescents and Young Adults with Cancer.

Authors:  Xiao-Cheng Wu; Pinki K Prasad; Ian Landry; Linda C Harlan; Helen M Parsons; Charles F Lynch; Ashley W Smith; Ann S Hamilton; Theresa H M Keegan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-29       Impact factor: 4.254

2.  The evaluation of three comorbidity indices in predicting postoperative complications and readmissions in pediatric urology.

Authors:  Ruiyang Jiang; Steven Wolf; Muhammad H Alkazemi; Gina-Maria Pomann; J Todd Purves; John S Wiener; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2018-02-26       Impact factor: 1.830

3.  Clostridium difficile infection in hospitalized children in the United States.

Authors:  Cade M Nylund; Anthony Goudie; Jose M Garza; Gerry Fairbrother; Mitchell B Cohen
Journal:  Arch Pediatr Adolesc Med       Date:  2011-01-03

4.  Predicting postoperative complications in pediatric surgery: A novel pediatric comorbidity index.

Authors:  Rohit Tejwani; Hui-Jie Lee; Taylor L Hughes; Kevin T Hobbs; Leonid I Aksenov; Charles D Scales; Jonathan C Routh
Journal:  J Pediatr Urol       Date:  2022-03-12       Impact factor: 1.921

5.  Identifying paediatric nursing-sensitive outcomes in linked administrative health data.

Authors:  Sally Wilson; Alexandra P Bremner; Yvonne Hauck; Judith Finn
Journal:  BMC Health Serv Res       Date:  2012-07-20       Impact factor: 2.655

6.  The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication data.

Authors:  Ji Hwan Bang; Soo-Hee Hwang; Eun-Jung Lee; Yoon Kim
Journal:  BMC Med Inform Decis Mak       Date:  2013-11-20       Impact factor: 2.796

7.  An empirical analysis of dealing with patients who are lost to follow-up when developing prognostic models using a cohort design.

Authors:  Jenna M Reps; Peter Rijnbeek; Alana Cuthbert; Patrick B Ryan; Nicole Pratt; Martijn Schuemie
Journal:  BMC Med Inform Decis Mak       Date:  2021-02-06       Impact factor: 2.796

8.  Long-Term Risk of Comorbidity after IgA Vasculitis in Childhood: A Population-Based Cohort Study.

Authors:  Johannes Nossent; Warren Raymond; Helen Keen; Charles Inderjeeth; David Preen
Journal:  Rheumatol Ther       Date:  2020-10-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.